Skip to main content

Day: April 1, 2023

Global Tech Industries Group, Inc. extends closing date with Wildfire Media Corp and the 1-800-LAW-FIRM brand to May 15, 2023

Written by Customer Service on . Posted in Public Companies.

New York, NY, March 31, 2023 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that it has signed a third extension agreement with Wildfire Media Corp, (“Wildfire”), extending the original agreement to May 15, 2023, in order to allow Wildfire more time to complete the two-year PCAOB audit undertaken by UHY, LLP, an auditing firm based in Sterling Heights, MI. The two-year audit is a requirement in order to complete and close the acquisition of Wildfire and the 1-800-LAWFIRM brand by GTII. About GTII: GTII is a publicly traded Company incorporated in the state of Nevada, specializing in the pursuit of acquiring new and innovative technologies. Visit GTII here https://gtii-us.com/ Please follow our Company at: www.otcmarkets.com/stock/GTII About Wildfire...

Continue reading

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

InterCure 2020-2022 Financials InterCure 2020-2022 FinancialsRecord fiscal year 2022 revenue of $150 million Record fiscal year 2022 Adjusted EBITDA* of $32 million Record fiscal year 2022 net income of $17 million Generated $20 Million cash flow from operations Strong balance sheet with over $95 million cash NEW YORK, TORONTO, and HERZLIYA, Israel, March 31, 2023 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted.Full Year 2022 Key Financial & Operating Highlights (Cannabis Sector)Record fiscal year 2022 revenue of $150 million...

Continue reading

Mydecine Reports Financial Results for the Year Ended December 2022

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

DENVER, March 31, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial results for the years ended December 31, 2022 and 2021. Company Highlights In 2022, Mydecine continued to define its focus and clinical trial execution strategy. The Company reached several milestones with the goal to become an efficiently operated biotechnology company. Of significant note, Mydecine announced several advancements in drug development including first and second-generation drug candidates. We have identified and pursued the indications that management believes will be most promising from the view of treating global...

Continue reading

IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update

Written by Customer Service on . Posted in Public Companies.

Revenue increased 14% annually driven by greater adoption of medical treatments. BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its financial results for the year ended December 31, 2022. Financial Highlights from FY 2022 (all comparisons are with IMAC for the year ended December 31 unless otherwise indicated):Annual revenue was $16.1 million, up 14.3% from $14.1 million in 2021 Patient revenue increased to $105 per visit compared to $84 per visit in 2021Corporate Highlights in Q4 2022 and Year To Date 2023:Completed the sale of The BackSpace to Curis Functional Health. Completed the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.